Document is current
Any future updates will be listed below
-
Authors
McConkey, Haley
van der Laan, Liselot
Ghosh, Sourav
Kleinendorst, Lotte
Levy, Michael A.
Rzasa, Jessica
van Hagen, Johanna M.
Waisfisz, Quinten
Schulz, Heidi L.
Heller, Corina
Huhn, Kerstin
Obermaier, Carolin D.
Platzer, Konrad
Jamra, Rami Abou
Marinakis, Nikos
Veltra, Danai
Kosma, Konstantina
Sofocleous, Christalena
Henneman, Peter
Sadikovic, Bekim
van Haelst, Mieke M.
-
Funding
Funding for this research was provided by:
Government of Canada through Genome Canada and the Ontario Genomics Institute (OGI-188)
- License Information
-
More Information
Article History
Received: 10 February 2026
Accepted: 7 June 2026
First Online: 20 July 2026
Declarations
Conflict of interest: BS is a shareholder in EpiSign Inc.
Ethical approval: Written informed consent was obtained from all individuals or family members prior to inclusion in this study including for the use of DNA and clinical information. The study was conducted in accordance with the regulations of the Western University Research Ethics Board (REB116108, and REB106302).
